In recent decades, the cancer research community has made great strides by bringing new, targeted, safer, and longer-lasting treatments to patients dealing with a variety of cancers. While this achievement is truly remarkable and laudable, a glaring fact is that these groundbreaking advances have not translated into progress for everyone.Read More
September is Ovarian Cancer Awareness Month. It’s an apt time for the American Association for Cancer Research (AACR) Advances in Ovarian Cancer Meeting, scheduled for Sept. 13-16 in Atlanta.
Ovarian cancer is a fairly rare cancer, accounting for only 1.3 percent of new cancer diagnoses in 2019. However, it is a deadly cancer, with only 47.6 percent of patients surviving for five years or longer. Because there are no good diagnostic tests for ovarian cancer, most patients are diagnosed at an advanced stage, when the disease is difficult to treat.Read More
In just over a month, the Georgia World Congress Center in Atlanta will host the American Association for Cancer Research (AACR) Annual Meeting 2019. This signature event showcases the latest and most promising developments in cancer research, drawing scientists, clinicians, advocates, and policymakers from around the world.Read More
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according to recent statistics. Unlike many other cancers, which can now be treated with checkpoint blockade immunotherapy, pancreatic cancer often does not respond to this type of treatment. One potential reason for this lack of efficacy is that pancreatic tumors tend to be nonimmunogenic, meaning that the cancer fails to elicit a strong immune response.Read More